AbbVie (ABBV) Interest Coverage Ratio: History & Chart

AbbVie Inc.(ABBV)

Drug Manufacturers - General · North Chicago, IL

$257.06+2.06 (+0.81%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

About AbbVie Inc.

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.

North Chicago, IL

57,000 employees

www.abbvie.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Michael

View full financials

ABBV Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

6.94x

INTEREST COVERAGE RATIO AVG TTM

6.51x

INTEREST COVERAGE RATIO AVG 3Y

5.91x

INTEREST COVERAGE RATIO AVG 5Y

6.58x

INTEREST COVERAGE RATIO AVG 10Y

7.01x

INTEREST COVERAGE RATIO AVG 15Y

7.40x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+6.60%

CURRENT VS 3Y AVG

+17.46%

CURRENT VS 5Y AVG

+5.49%

CURRENT VS 10Y AVG

-0.94%

CURRENT VS 15Y AVG

-6.25%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+0.80%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
AbbVie Inc. (ABBV)	$454.17B	6.94x	6.51x	5.91x	6.58x
Merck & Co., Inc. (MRK)vs ›	$355.49B	17.31x	16.61x	13.70x	12.98x
UnitedHealth Group Incorporated (UNH)vs ›	$344.27B	4.74x	6.50x	9.14x	10.75x
Roche Holding AG (RHHBY)vs ›	$336.71B	14.34x	11.95x	16.17x	26.28x
Johnson & Johnson (JNJ)vs ›	$640.02B	26.36x	27.85x	40.54x	62.46x
AstraZeneca PLC (AZN)vs ›	$248.40B	8.11x	7.03x	5.51x	4.49x
Thermo Fisher Scientific Inc. (TMO)vs ›	$226.62B	5.71x	5.17x	6.77x	10.10x
Amgen Inc. (AMGN)vs ›	$203.66B	3.88x	3.09x	3.93x	4.89x
Novo Nordisk A/S (NVO)vs ›	$191.26B	30.34x	54.30x	123.94x	139.58x
Gilead Sciences, Inc. (GILD)vs ›	$178.44B	11.43x	6.56x	7.26x	7.18x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

AbbVie Inc. (ABBV)

$454.17B

6.94x

6.51x

5.91x

6.58x

Merck & Co., Inc. (MRK)vs ›

$355.49B

17.31x

16.61x

13.70x

12.98x

UnitedHealth Group Incorporated (UNH)vs ›

$344.27B

4.74x

6.50x

9.14x

10.75x

Roche Holding AG (RHHBY)vs ›

$336.71B

14.34x

11.95x

16.17x

26.28x

Johnson & Johnson (JNJ)vs ›

$640.02B

26.36x

27.85x

40.54x

62.46x

AstraZeneca PLC (AZN)vs ›

$248.40B

8.11x

7.03x

5.51x

4.49x

Thermo Fisher Scientific Inc. (TMO)vs ›

$226.62B

5.71x

5.17x

6.77x

10.10x

Amgen Inc. (AMGN)vs ›

$203.66B

3.88x

3.09x

3.93x

4.89x

Novo Nordisk A/S (NVO)vs ›

$191.26B

30.34x

54.30x

123.94x

139.58x

Gilead Sciences, Inc. (GILD)vs ›

$178.44B

11.43x

6.56x

7.26x

7.18x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for AbbVie Inc. (ABBV)?

The interest coverage ratio for ABBV stock is 6.94x.

Is AbbVie Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 6.94x is in line with its 5-year average of 6.58x, near the high end of its 5-year range (-2.12x–9.72x).

What is the TTM average interest coverage ratio for AbbVie Inc. (ABBV)?

The TTM average interest coverage ratio for ABBV stock is 6.51x.

What is the 3Y average interest coverage ratio for AbbVie Inc. (ABBV)?

The 3Y average interest coverage ratio for ABBV stock is 5.91x.

What is the 5Y average interest coverage ratio for AbbVie Inc. (ABBV)?

The 5Y average interest coverage ratio for ABBV stock is 6.58x.

What is the 10Y average interest coverage ratio for AbbVie Inc. (ABBV)?

The 10Y average interest coverage ratio for ABBV stock is 7.01x.

What is the 15Y average interest coverage ratio for AbbVie Inc. (ABBV)?

The 15Y average interest coverage ratio for ABBV stock is 7.40x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	8.62x
2026-03-31	6.60x
2025-12-31	8.14x
2025-09-30	2.58x
2025-06-30	6.61x
2025-03-31	5.33x
2024-12-31	-2.12x
2024-09-30	5.32x
2024-06-30	5.51x
2024-03-31	4.24x
2023-12-31	5.66x
2023-09-30	4.11x
2023-06-30	8.18x
2023-03-31	5.01x
2022-12-31	9.72x
2022-09-30	8.22x
2022-06-30	5.93x
2022-03-31	8.61x
2021-12-31	8.75x
2021-09-30	7.22x
2021-06-30	7.22x
2021-03-31	6.49x
2020-12-31	5.97x
2020-09-30	5.17x
2020-06-30	1.19x
2020-03-31	6.40x
2019-12-31	7.08x
2019-09-30	5.45x
2019-06-30	9.50x
2019-03-31	7.78x
2018-12-31	-6.42x
2018-09-30	9.32x
2018-06-30	8.63x
2018-03-31	9.39x
2017-12-31	6.00x
2017-09-30	9.19x
2017-06-30	9.37x
2017-03-31	8.82x
2016-12-31	7.46x
2016-09-30	8.71x
2016-06-30	9.74x
2016-03-31	10.60x
2015-12-31	10.16x
2015-09-30	9.11x
2015-06-30	10.77x
2015-03-31	12.78x
2014-12-31	-2.99x
2014-09-30	6.49x
2014-06-30	20.75x
2014-03-31	19.30x
2013-12-31	20.74x
2013-09-30	18.28x
2013-06-30	18.39x
2013-03-31	18.13x
2012-09-30	159.60x

DATE

INTEREST COVERAGE RATIO

2026-06-30

8.62x

2026-03-31

6.60x

2025-12-31

8.14x

2025-09-30

2.58x

2025-06-30

6.61x

2025-03-31

5.33x

2024-12-31

-2.12x

2024-09-30

5.32x

2024-06-30

5.51x

2024-03-31

4.24x

2023-12-31

5.66x

2023-09-30

4.11x

2023-06-30

8.18x

2023-03-31

5.01x

2022-12-31

9.72x

2022-09-30

8.22x

2022-06-30

5.93x

2022-03-31

8.61x

2021-12-31

8.75x

2021-09-30

7.22x

2021-06-30

7.22x

2021-03-31

6.49x

2020-12-31

5.97x

2020-09-30

5.17x

2020-06-30

1.19x

2020-03-31

6.40x

2019-12-31

7.08x

2019-09-30

5.45x

2019-06-30

9.50x

2019-03-31

7.78x

2018-12-31

-6.42x

2018-09-30

9.32x

2018-06-30

8.63x

2018-03-31

9.39x

2017-12-31

6.00x

2017-09-30

9.19x

2017-06-30

9.37x

2017-03-31

8.82x

2016-12-31

7.46x

2016-09-30

8.71x

2016-06-30

9.74x

2016-03-31

10.60x

2015-12-31

10.16x

2015-09-30

9.11x

2015-06-30

10.77x

2015-03-31

12.78x

2014-12-31

-2.99x

2014-09-30

6.49x

2014-06-30

20.75x

2014-03-31

19.30x

2013-12-31

20.74x

2013-09-30

18.28x

2013-06-30

18.39x

2013-03-31

18.13x

2012-09-30

159.60x

Interest Coverage Ratio: 6.94x

ABBV Interest Coverage Ratio

ABBV Average Interest Coverage Ratio Chart

ABBV Current vs Average Interest Coverage Ratio Chart

ABBV Interest Coverage Ratio Metrics

ABBV Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

ABBV Interest Coverage Ratio History

Related Metrics